Cancer

Items 11-20 of 25

Page
per page
Set Descending Direction
  1. anti-CD40 (human), mAb (EA-5)
    ANC-300-020.
    ANC-300-020100 µg
    CHF 260.00
  2. anti-CD40 (human), mAb (EA-5) (Biotin)
    ANC-300-030.
    ANC-300-030100 µg
    CHF 306.00
  3. anti-CD40 (human), mAb (EA-5) (FITC)
    ANC-300-040.
    ANC-300-040120 tests
    CHF 306.00
  4. anti-CD40 (human), mAb (EA-5) (preservative free)
    ANC-300-820.
    ANC-300-820100 µg
    CHF 260.00
  5. anti-CD40 (human), mAb (EA-5) (R-PE)
    ANC-300-050.
    ANC-300-050120 tests
    CHF 390.00
  6. anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
    AG-20B-6001YPF
    AG-20B-6001YPF-C100100 µg
    CHF 290.00
    AG-20B-6001YPF-C500500 µg
    CHF 730.00
    Replaces AG-20B-6001PF
    anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
  7. anti-Hairy and Enhancer of Split 1 (HES1), mAb (7H11)
    AG-20T-0400
    AG-20T-0400-C100100 µg
    CHF 380.00
    Western blot analysis using anti-HES1, mAb (7H11) (Prod. No. AG-20T-0400) in cell lysates. Lane1: HeLa cell lysate; Lane 2: HT29 cell lysate; Lane 3: BeWo cell lysate.
  8. anti-HMGB1, mAb (rec.) (Giby-1-4)
    AG-27B-0002
    AG-27B-0002-C100100 µg
    CHF 350.00
    Western blot analysis of human and rat HMGB1 using anti-HMGB1, mAb (rec.) (GIBY-1-4) (Prod. No. AG-27B-0002)
Different amounts of cell extracts from HEK293T cells (3μg, 5μg and 30μg) either transfected with a plasmid coding for rat HMGB1 (l
  9. anti-HMGB1, mAb (rec.) (Giby-1-4) (Biotin)
    AG-27B-0002B
    AG-27B-0002B-C100100 µg
    CHF 395.00
    anti-HMGB1, mAb (rec.) (Giby-1-4) (Biotin)
  10. anti-Lipocalin-2 (human), pAb
    AG-25A-0087
    AG-25A-0087-C100100 µg
    CHF 190.00
    Western blot analysis using anti-Lipocalin-2 (human), pAb (Prod. No. AG-25A-0087) at 1:4'000 dilution.
1: Human Lipocalin-2 (FLAG®-tagged).
2: Mouse Lipocalin-2 (FLAG®-tagged).
3: Rat Lipocalin-2 (FLAG®-t

Items 11-20 of 25

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.